Vitamin D-immunoassay reagent

Active Purchase Order Awarded Last action

Contract number
W81K0024P0021
Awardee
Awarding agency
Obligated
$528,334

Award facts

Opportunity
Contract value 46% obligated
  • $624,980.04 Current, with exercised options
  • $1,139,183.24 Potential, with all options
Completion date 52% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Johnson South, LA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00007 · Transfer/FY24 deobligation clins 0001- 00059 -chemistry and immunoassay testing -$83,866
Change Order P00006 · FY26 increase clins and options -added clins 2072, 3072, and 4072. Chemistry and immunoassay testing $31,762
Funding Only Action P00005 $3,473
Novation Agreement P00003 · Chemistry and immunoassay testing $260,017
Exercise an Option P00002 $0
Funding Only Action P00001 $83,866
Modification $0
Exercise an Option P00004 · Chemistry and immunoassay testing $233,083

About this award

The Defense Health Agency awarded a purchase order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, for vitamin D immunoassay reagent and chemistry and immunoassay testing supplies on April 1, 2024, with a ceiling value of $1,139,183.24. Work is performed at Fort Johnson South, Louisiana. The order covers transfer and fiscal year 2024 deobligation of CLINs 0001–00059 under a firm fixed-price structure with an ultimate completion date of March 31, 2029. The originating solicitation, posted October 20, 2023, sought leased chemistry and immunoassay integrated analyzers and reagent testing supplies for Bayne Jones Army Community Hospital under a cost-per-reportable-result agreement, with a government estimate of $546,640 annually or $2,733,200 over five years if all options were exercised.

Quick answers

Who was awarded contract W81K0024P0021?

W81K0024P0021 was awarded to Quidelortho Sales Company, LLC by Medical Command (Department of the Army) on April 1, 2024.

How much is contract W81K0024P0021 worth?

The government has obligated $528,334 on W81K0024P0021. Its current value, with exercised options, is $624,980. Its potential value, with all options, is $1,139,183.

Which agency awarded contract W81K0024P0021?

Medical Command (Department of the Army) awarded W81K0024P0021, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0024P0021 competed?

The extent of competition for W81K0024P0021 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award